Abrocitinib or Cibinqo (its brand name) targets moderate-to-severe eczema and is meant for patients whose condition is not adequately controlled using topical medications.Read More
Abrocitinib or Cibinqo (its brand name) targets moderate-to-severe eczema and is meant for patients whose condition is not adequately controlled using topical medications.Read More